PVR and neoplasm: DNAM-1/CD155 axis has raised interest in the context of anti-tumor immune response since DNAM-1-deficient mice are more prone to develop carcinogen-induced tumors compared to their wild type counterparts and exhibit accelerated CD155-positive transplanted tumor growth [40,41].